Product Details for ANDA 076690
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE)
EQ 25MG BASE
Marketing Status: Prescription
EQ 37.5MG BASE
Marketing Status: Prescription
EQ 50MG BASE
Marketing Status: Prescription
EQ 75MG BASE
Marketing Status: Prescription
EQ 100MG BASE
Marketing Status: Prescription
EQ 25MG BASE
Marketing Status: Prescription
Active Ingredient: VENLAFAXINE HYDROCHLORIDE
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 25MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076690
Product Number: 001
Approval Date: Aug 3, 2006
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE)
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 25MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076690
Product Number: 001
Approval Date: Aug 3, 2006
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 37.5MG BASE
Marketing Status: Prescription
Active Ingredient: VENLAFAXINE HYDROCHLORIDE
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 37.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076690
Product Number: 002
Approval Date: Aug 3, 2006
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE)
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 37.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076690
Product Number: 002
Approval Date: Aug 3, 2006
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 50MG BASE
Marketing Status: Prescription
Active Ingredient: VENLAFAXINE HYDROCHLORIDE
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 50MG BASE
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AB
Application Number: A076690
Product Number: 003
Approval Date: Aug 3, 2006
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE)
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 50MG BASE
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AB
Application Number: A076690
Product Number: 003
Approval Date: Aug 3, 2006
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 75MG BASE
Marketing Status: Prescription
Active Ingredient: VENLAFAXINE HYDROCHLORIDE
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 75MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076690
Product Number: 004
Approval Date: Aug 3, 2006
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE)
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 75MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076690
Product Number: 004
Approval Date: Aug 3, 2006
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 100MG BASE
Marketing Status: Prescription
Active Ingredient: VENLAFAXINE HYDROCHLORIDE
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 100MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076690
Product Number: 005
Approval Date: Aug 3, 2006
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: VENLAFAXINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 100MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076690
Product Number: 005
Approval Date: Aug 3, 2006
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status: Prescription
Patent and Exclusivity Information